-
1
-
-
33645732219
-
Molecular pathology of malignant gliomas
-
Louis DN. Molecular pathology of malignant gliomas. Annu Rev Pathol Mech Dis 2006;1:97-117.
-
(2006)
Annu Rev Pathol Mech Dis
, vol.1
, pp. 97-117
-
-
Louis, D.N.1
-
2
-
-
20044366163
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
-
Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96.
-
(2005)
N Engl J Med
, vol.352
, pp. 987-996
-
-
Stupp, R.1
Mason, W.P.2
van den Bent, M.J.3
-
3
-
-
33646256145
-
A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy
-
Hunter C, Smith R, Cahill DP, et al. A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. Cancer Res 2006;66:3987-91.
-
(2006)
Cancer Res
, vol.66
, pp. 3987-3991
-
-
Hunter, C.1
Smith, R.2
Cahill, D.P.3
-
4
-
-
3042531072
-
Mismatch repair genes identified using genetic screens in Blm-deficient embryonic stem cells
-
Guo G, Wang W, Bradley A. Mismatch repair genes identified using genetic screens in Blm-deficient embryonic stem cells. Nature 2004;429:891-5.
-
(2004)
Nature
, vol.429
, pp. 891-895
-
-
Guo, G.1
Wang, W.2
Bradley, A.3
-
5
-
-
0032851842
-
Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents
-
Hickman MJ, Samson LD. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc Natl Acad Sci U S A 1999;96: 10764-9.
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, pp. 10764-10769
-
-
Hickman, M.J.1
Samson, L.D.2
-
6
-
-
0027292234
-
An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair
-
Kat A, Thilly WG, Fang WH, Longley MJ, Li GM, Modrich P. An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc Natl Acad Sci U S A 1993;90:6424-8.
-
(1993)
Proc Natl Acad Sci U S A
, vol.90
, pp. 6424-6428
-
-
Kat, A.1
Thilly, W.G.2
Fang, W.H.3
Longley, M.J.4
Li, G.M.5
Modrich, P.6
-
7
-
-
0034733020
-
Mismatch repair deficient human cells: Spontaneous and MNNG-induced mutational spectra in the HPRT gene
-
Tomita-Mitchell A, Kat AG, Marcelino LA, Li-Sucholeiki XC, Goodluck-Griffith J, Thilly WG. Mismatch repair deficient human cells: spontaneous and MNNG-induced mutational spectra in the HPRT gene. Mutat Res 2000;450:125-38.
-
(2000)
Mutat Res
, vol.450
, pp. 125-138
-
-
Tomita-Mitchell, A.1
Kat, A.G.2
Marcelino, L.A.3
Li-Sucholeiki, X.C.4
Goodluck-Griffith, J.5
Thilly, W.G.6
-
8
-
-
19644386509
-
Characterization of the mismatch repair defect in the human lymphoblastold MT1 cells
-
Szadkowski M, Iaccarino I, Heinimann K, Marra G, Jiricny J. Characterization of the mismatch repair defect in the human lymphoblastold MT1 cells. Cancer Res 2005;65:4525-9.
-
(2005)
Cancer Res
, vol.65
, pp. 4525-4529
-
-
Szadkowski, M.1
Iaccarino, I.2
Heinimann, K.3
Marra, G.4
Jiricny, J.5
-
9
-
-
0030776227
-
Correction of hypermutability, N-methyl-N′-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6
-
Umar A, Koi M, Risinger JI, et al. Correction of hypermutability, N-methyl-N′-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Res 1997;57:3949-55.
-
(1997)
Cancer Res
, vol.57
, pp. 3949-3955
-
-
Umar, A.1
Koi, M.2
Risinger, J.I.3
-
10
-
-
0033065150
-
Effect of hMSH6 cDNA expression on the phenotype of mismatch repair-deficient colon cancer cell line HCT15
-
Lettieri T, Marra G, Aquilina G, et al. Effect of hMSH6 cDNA expression on the phenotype of mismatch repair-deficient colon cancer cell line HCT15. Carcinogenesis 1999;20:373-82.
-
(1999)
Carcinogenesis
, vol.20
, pp. 373-382
-
-
Lettieri, T.1
Marra, G.2
Aquilina, G.3
-
11
-
-
33646187811
-
The multifaceted mismatch-repair system
-
Jiricny J. The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol 2006;7:335-46.
-
(2006)
Nat Rev Mol Cell Biol
, vol.7
, pp. 335-346
-
-
Jiricny, J.1
-
12
-
-
27644596327
-
A homozygous mutation in MSH6 causes Turcot syndrome
-
Hegde MR, Chong B, Blazo ME, et al. A homozygous mutation in MSH6 causes Turcot syndrome. Clin Cancer Res 2005;11:4689-93.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 4689-4693
-
-
Hegde, M.R.1
Chong, B.2
Blazo, M.E.3
-
13
-
-
16544395180
-
A homozygous MSH6 mutation in a child with cafe-au-lait spots, oligodendroglioma and rectal cancer
-
Menko FH, Kaspers GL, Meijer GA, Claes K, van Hagen JM, Gille JJ. A homozygous MSH6 mutation in a child with cafe-au-lait spots, oligodendroglioma and rectal cancer. Fam Cancer 2004;3:123-7.
-
(2004)
Fam Cancer
, vol.3
, pp. 123-127
-
-
Menko, F.H.1
Kaspers, G.L.2
Meijer, G.A.3
Claes, K.4
van Hagen, J.M.5
Gille, J.J.6
-
14
-
-
2442708840
-
Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history
-
Buttin BM, Powell MA, Mutch DG, et al. Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. Am J Hum Genet 2004;74:1262-9.
-
(2004)
Am J Hum Genet
, vol.74
, pp. 1262-1269
-
-
Buttin, B.M.1
Powell, M.A.2
Mutch, D.G.3
-
15
-
-
18244380349
-
Molecular and clinical characteristics of MSH6 variants: An analysis of 25 index carriers of a germline variant
-
Berends MJ, Wu Y, Sijmons RH, et al. Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant. Am J Hum Genet 2002;70:26-37.
-
(2002)
Am J Hum Genet
, vol.70
, pp. 26-37
-
-
Berends, M.J.1
Wu, Y.2
Sijmons, R.H.3
-
16
-
-
0028970197
-
The molecular basis of Turcots syndrome
-
Hamilton SR, Liu B, Parsons RE, et al. The molecular basis of Turcots syndrome. N Engl J Med 1995;332: 839-47.
-
(1995)
N Engl J Med
, vol.332
, pp. 839-847
-
-
Hamilton, S.R.1
Liu, B.2
Parsons, R.E.3
-
17
-
-
20044372154
-
MGMT gene silencing and benefit from temozolomide in glioblastoma
-
Hegi ME, Diserens A, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005;352:997-1003.
-
(2005)
N Engl J Med
, vol.352
, pp. 997-1003
-
-
Hegi, M.E.1
Diserens, A.2
Gorlia, T.3
-
18
-
-
0032588748
-
6-Methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: Frequency and time to tumor progression after alkylating agent-based chemotherapy
-
6-Methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy. Clin Cancer Res 1999;5:807-14.
-
(1999)
Clin Cancer Res
, vol.5
, pp. 807-814
-
-
Silber, J.R.1
Blank, A.2
Bobola, M.S.3
Ghatan, S.4
Kolstoe, D.D.5
Berger, M.S.6
-
19
-
-
11244327596
-
6-methylguanine-DNA methyltransferase in the non-neoplastic and neoplastic components of gliomas
-
6-methylguanine-DNA methyltransferase in the non-neoplastic and neoplastic components of gliomas. J Neurooncol 2004;70: 333-40.
-
(2004)
J Neurooncol
, vol.70
, pp. 333-340
-
-
Nakasu, S.1
Fukami, T.2
Baba, K.3
Matsuda, M.4
-
20
-
-
0034046394
-
Epigenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents
-
Bearzatto A, Szadkowski M, Macpherson P, Jiricny J, Karran P. Epigenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents. Cancer Res 2000;60:3262-70.
-
(2000)
Cancer Res
, vol.60
, pp. 3262-3270
-
-
Bearzatto, A.1
Szadkowski, M.2
Macpherson, P.3
Jiricny, J.4
Karran, P.5
-
21
-
-
0030479125
-
Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea
-
Liu LL, Markowitz S, Gerson SL. Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Cancer Res 1996;56: 5375-9.
-
(1996)
Cancer Res
, vol.56
, pp. 5375-5379
-
-
Liu, L.L.1
Markowitz, S.2
Gerson, S.L.3
-
22
-
-
0442299319
-
A semiparametric model for randomly truncated data
-
Wang M-C. A semiparametric model for randomly truncated data. J Am Stat Assoc 1989;84:742-8.
-
(1989)
J Am Stat Assoc
, vol.84
, pp. 742-748
-
-
Wang, M.-C.1
-
23
-
-
33745658837
-
Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer
-
Barnetson RA, Tenesa A, Farrington SM, et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 2006;354:2751-63.
-
(2006)
N Engl J Med
, vol.354
, pp. 2751-2763
-
-
Barnetson, R.A.1
Tenesa, A.2
Farrington, S.M.3
-
24
-
-
17944362664
-
Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)
-
Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005;352:1851-60.
-
(2005)
N Engl J Med
, vol.352
, pp. 1851-1860
-
-
Hampel, H.1
Frankel, W.L.2
Martin, E.3
-
25
-
-
0032435612
-
DNA mismatch repair and O-6-alkylguanine-DNA alkyltransferase analysis and response to temodal in newly diagnosed malignant glioma
-
Friedman HS, McLendon RE, Kerby T, et al. DNA mismatch repair and O-6-alkylguanine-DNA alkyltransferase analysis and response to temodal in newly diagnosed malignant glioma. J Clin Oncol 1998;16: 3851-7.
-
(1998)
J Clin Oncol
, vol.16
, pp. 3851-3857
-
-
Friedman, H.S.1
McLendon, R.E.2
Kerby, T.3
-
26
-
-
0027502938
-
Defective mismatch binding and a mutator phenotype in cells tolerant to DNA Damage
-
Branch P, Aquilina G, Bignami M, Karran P. Defective mismatch binding and a mutator phenotype in cells tolerant to DNA Damage. Nature 1993;362: 652-4.
-
(1993)
Nature
, vol.362
, pp. 652-654
-
-
Branch, P.1
Aquilina, G.2
Bignami, M.3
Karran, P.4
-
28
-
-
2442706833
-
Dependence of the cytotoxicity of DNA-damaging agents on the mismatch repair status of human cells
-
Papouli E, Cejka P, Jiricny J. Dependence of the cytotoxicity of DNA-damaging agents on the mismatch repair status of human cells. Cancer Res 2004; 64:3391-4.
-
(2004)
Cancer Res
, vol.64
, pp. 3391-3394
-
-
Papouli, E.1
Cejka, P.2
Jiricny, J.3
-
29
-
-
0032694518
-
Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents
-
Liu L, Taverna P, Whitacre CM, Chatterjee S, Gerson SL. Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents. Clin Cancer Res 1999;5:2908-17.
-
(1999)
Clin Cancer Res
, vol.5
, pp. 2908-2917
-
-
Liu, L.1
Taverna, P.2
Whitacre, C.M.3
Chatterjee, S.4
Gerson, S.L.5
-
30
-
-
22244448679
-
The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death
-
Trivedi RN, Almeida KH, Fornsaglio JL, Schamus S, Sobol RW. The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death. Cancer Res 2005;65:6394-400.
-
(2005)
Cancer Res
, vol.65
, pp. 6394-6400
-
-
Trivedi, R.N.1
Almeida, K.H.2
Fornsaglio, J.L.3
Schamus, S.4
Sobol, R.W.5
-
31
-
-
0037310904
-
6-alkylguanine-DNA alkyltransferase and mismatch repair activities on the sensitivity of human melanoma cells to temozolomide, 1,3-bis(2-chloroethyl) 1-nitrosourea, and cisplatin
-
6-alkylguanine-DNA alkyltransferase and mismatch repair activities on the sensitivity of human melanoma cells to temozolomide, 1,3-bis(2-chloroethyl) 1-nitrosourea, and cisplatin. J Pharmacol Exp Ther 2003;304:661-8.
-
(2003)
J Pharmacol Exp Ther
, vol.304
, pp. 661-668
-
-
Pepponi, R.1
Marra, G.2
Fuggetta, M.P.3
-
32
-
-
9144268289
-
Dose-dense regimen of temozolomide given every other week in patients with primary central nervous system tumors
-
Vera K, Djafari L, Faivre S, et al. Dose-dense regimen of temozolomide given every other week in patients with primary central nervous system tumors. Ann Oncol 2004;15:161-71.
-
(2004)
Ann Oncol
, vol.15
, pp. 161-171
-
-
Vera, K.1
Djafari, L.2
Faivre, S.3
-
33
-
-
33646503204
-
ATR kinase activation mediated by MutSα and MutLα in response to cytotoxic O(6)-methylguanine adducts
-
Yoshioka K, Yoshioka Y, Hsieh P. ATR kinase activation mediated by MutSα and MutLα in response to cytotoxic O(6)-methylguanine adducts. Mol Cell 2006;22:501-10.
-
(2006)
Mol Cell
, vol.22
, pp. 501-510
-
-
Yoshioka, K.1
Yoshioka, Y.2
Hsieh, P.3
-
34
-
-
0036567603
-
Phosphorylation of mismatch repair proteins MSH2 and MSH6 affecting MutSα mismatch-binding activity
-
Christmann M, Tomicic MT, Kaina B. Phosphorylation of mismatch repair proteins MSH2 and MSH6 affecting MutSα mismatch-binding activity. Nucleic Acids Res 2002;30:1959-66.
-
(2002)
Nucleic Acids Res
, vol.30
, pp. 1959-1966
-
-
Christmann, M.1
Tomicic, M.T.2
Kaina, B.3
-
35
-
-
0029143992
-
Evidence for a connection between the mismatch repair system and the G(2) cell-cycle checkpoint
-
Hawn MT, Umar A, Carethers JM, et al. Evidence for a connection between the mismatch repair system and the G(2) cell-cycle checkpoint. Cancer Res 1995;55:3721-5.
-
(1995)
Cancer Res
, vol.55
, pp. 3721-3725
-
-
Hawn, M.T.1
Umar, A.2
Carethers, J.M.3
-
36
-
-
0035266426
-
Microsatellite instability occurs in distinct subtypes of pediatric but not adult central nervous system tumors
-
Alonso M, Hamelin R, Kim M, et al. Microsatellite instability occurs in distinct subtypes of pediatric but not adult central nervous system tumors. Cancer Res 2001;61:2124-8.
-
(2001)
Cancer Res
, vol.61
, pp. 2124-2128
-
-
Alonso, M.1
Hamelin, R.2
Kim, M.3
-
37
-
-
4444339673
-
Molecular mechanisms associated with chromosomal and microsatellite instability in sporadic glioblastoma multiforme
-
Martinez R, Schackert HK, Plaschke J, Baretton G, Appelt H, Schackert G. Molecular mechanisms associated with chromosomal and microsatellite instability in sporadic glioblastoma multiforme. Oncology 2004; 66:395-403.
-
(2004)
Oncology
, vol.66
, pp. 395-403
-
-
Martinez, R.1
Schackert, H.K.2
Plaschke, J.3
Baretton, G.4
Appelt, H.5
Schackert, G.6
|